Joud Hajjar
Overview
Explore the profile of Joud Hajjar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
877
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ahmed J, Choi Y, Ko T, Lim J, Hajjar J
J Immunother Precis Oncol
. 2025 Jan;
8(1):34-46.
PMID: 39811426
Immunoglobulins (Igs) are produced by B lymphocytes and play a key role in humoral immunity. Igs are classified into five isotypes (IgG, IgA, IgM, IgE, and IgD). Their primary function...
2.
Salih A, Brown A, Grimes A, Hasan S, Silva-Carmona M, Tal L, et al.
Front Pediatr
. 2024 Oct;
12:1417724.
PMID: 39359743
Common variable immunodeficiency (CVID) can be complicated by granulomatous disease, often granulomatous lymphocytic interstitial lung disease (GLILD). Granulomatous interstitial nephritis represents an atypical presentation in pediatrics. Our patient is a...
3.
Hajjar J, Derbala M, Naing A
JAMA Oncol
. 2023 Sep;
9(11):1503-1504.
PMID: 37768657
No abstract available.
4.
Stephen B, Hajjar J, Sarda S, Duose D, Conroy J, Morrison C, et al.
J Immunother Cancer
. 2023 Aug;
11(8).
PMID: 37604642
Background: Immune checkpoint inhibitors have revolutionized cancer treatment. However, they are associated with a unique spectrum of side effects, called immune-related adverse events (irAEs), which can cause significant morbidity and...
5.
Hajjar J, Voigt A, Conner M, Swennes A, Fowler S, Calarge C, et al.
Res Sq
. 2023 Mar;
PMID: 36993518
Purpose: Patients with non-infectious complications have worse clinical outcomes in common variable immunodeficiency (CVID) than those with infections-only. Non-infectious complications are associated with gut microbiome aberrations, but there are no...
6.
Salih A, Chin A, Gandhi M, Shamshirsaz A, Lombaard H, Hajjar J
J Allergy Clin Immunol Pract
. 2022 Dec;
11(3):961-962.
PMID: 36572180
No abstract available.
7.
Ness T, Erickson T, Diaz V, Grimes A, Rochat R, Anvari S, et al.
J Pediatr
. 2022 Oct;
253:232-237.e1.
PMID: 36195311
Objectives: To identify the etiology of peripheral eosinophilia in a large pediatric population and to develop a diagnostic algorithm to help guide diagnosis and management of peripheral eosinophilia in the...
8.
Syed M, Kutac C, Miller J, Marsh R, Sullivan K, Cunningham-Rundles C, et al.
J Clin Immunol
. 2022 Jul;
42(7):1545-1552.
PMID: 35779201
Background: Despite immunoglobulin replacement (IgRT) therapy, some patients with primary antibody deficiency (PAD) continue to develop respiratory infections. Recurrent and severe respiratory infections, particularly pneumonia, can lead to significant morbidity...
9.
Balasubramanyam S, Hajjar J
J Immunother Precis Oncol
. 2022 Jun;
4(1):21-25.
PMID: 35664823
Soft-tissue sarcomas associated with eosinophilia are rare, with limited cases reported in adults, and even fewer in the pediatric population. In this report, we highlight the importance of malignancy in...
10.
Xu M, Tapia C, Hajjar J, Sabir S, Colen R, Nagarajan P, et al.
J Immunother Precis Oncol
. 2022 Jun;
4(2):45-52.
PMID: 35663531
Introduction: For maximum utility of molecular characterization by next-generation sequencing (NGS) and better understanding of tumor microenvironment with immune correlates analysis, biopsy specimens must yield adequate tumor tissue, and sequential...